doi: 10.1016/j.celrep.2014.10.032 68 GrassetEPuelACharpentierJColletXChristensenJETercFet al
Be patient it's a gradual process, but many users report steady progress over time
This is on par with or even better than the data supporting GLP1 medications like Ozempic and Wegovy And thats a crucial point, because those drugs on average cost about $13,000 per year
Receptor Comparison# Weight Loss Efficacy# Retatrutide Phase 2 Results# The Phase 2 obesity trial (Jastreboff et al., NEJM 2023
The sections below walk through the schedules, the modelling, and the tradeoffs
How PlexusDx Supports a More Personalized Approach PlexusDx genetic insights into GLP1R, GIPR, MC4R, and FTO variants may help provide context for understanding why your tolerability profile differs from a friend or family member on the same medication